Kapiteijn Kitty, Koolwijk Pieter, van der Weiden Robin M F, van Nieuw Amerongen Geerten, Plaisier Margreet, van Hinsbergh Victor W M, Helmerhorst Frans M
Division of Biomedical Research, TNO Quality of Life, Leiden, The Netherlands.
Fertil Steril. 2006 Apr;85 Suppl 1:1232-9. doi: 10.1016/j.fertnstert.2005.11.029.
Successful implantation and placentation depend on the interaction between the endometrium and the embryo. Angiogenesis is crucial at this time. In this article we investigate the direct influence of the human embryo on in vitro endometrial angiogenesis.
In vitro study.
Human endometrial microvascular endothelial cells (hEMVEC) grown on an in vitro angiogenesis model.
INTERVENTION(S): Conditioned media (CM) of human embryos were used to stimulate in vitro angiogenesis.
MAIN OUTCOME MEASURE(S): In vitro angiogenesis of hEMVEC.
RESULT(S): Conditioned media of human embryos, containing significant amounts of vascular endothelial growth factor (VEGF)-A, as determined by enzyme-linked immunosorbent assay (ELISA), caused an increase in hEMVEC tube formation. This effect was prevented by soluble VEGF receptor 1, which quenches VEGF-A activity. Recombinant EGF alone and leukemia inhibitory factor in combination with VEGF-A stimulated hEMVEC tube formation. None of the other tested recombinant mediators, which have been described as produced by the early embryo/trophoblast (interleukin (IL) 10, transforming growth factor (TGF) beta, placental growth factor, hCG, colony-stimulating factor 1, interferon-gamma, insulin-like growth factor I and II, IL-6, platelet-derived growth factor, and TGFalpha), had an effect on tube formation by hEMVEC.
CONCLUSION(S): For the first time, it is shown that the human embryo is able to stimulate in vitro endometrial angiogenesis at the time of implantation, a process that is mediated by VEGF-A.
成功着床和胎盘形成取决于子宫内膜与胚胎之间的相互作用。血管生成在此时至关重要。在本文中,我们研究了人类胚胎对体外子宫内膜血管生成的直接影响。
体外研究。
在体外血管生成模型上培养的人子宫内膜微血管内皮细胞(hEMVEC)。
使用人类胚胎的条件培养基(CM)刺激体外血管生成。
hEMVEC的体外血管生成。
通过酶联免疫吸附测定(ELISA)确定,人类胚胎的条件培养基含有大量血管内皮生长因子(VEGF)-A,可导致hEMVEC管形成增加。可溶性VEGF受体1可阻断VEGF-A活性,从而阻止这种效应。单独的重组表皮生长因子(EGF)以及白血病抑制因子与VEGF-A联合使用可刺激hEMVEC管形成。早期胚胎/滋养层产生的其他测试重组介质(白细胞介素(IL)10、转化生长因子(TGF)β、胎盘生长因子、hCG、集落刺激因子1、干扰素-γ、胰岛素样生长因子I和II、IL-6、血小板衍生生长因子和TGFα)对hEMVEC的管形成均无影响。
首次表明人类胚胎在着床时能够刺激体外子宫内膜血管生成,这一过程由VEGF-A介导。